• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

T细胞激活过程中CTLA-4表达的调控。

Regulation of CTLA-4 expression during T cell activation.

作者信息

Perkins D, Wang Z, Donovan C, He H, Mark D, Guan G, Wang Y, Walunas T, Bluestone J, Listman J, Finn P W

机构信息

Renal Division, Brigham and Women's Hospitals, Boston, MA 02115, USA.

出版信息

J Immunol. 1996 Jun 1;156(11):4154-9.

PMID:8666782
Abstract

T cell activation requires at least two distinct signals, including signaling via the Ag-specific TCR and a costimulatory pathway. The best characterized costimulatory pathway involves the CD28 molecule, which is expressed constitutively on T cells and binds the family of B7 counter-receptors on APCs. Inhibition of this costimulatory pathway prevents T cell activation and can lead to long-term T cell unresponsiveness or anergy. In contrast, CTLA4, which is homologous to CD28, has been shown to be a negative regulator of T cell activation. The CTLA4 molecule is not expressed on resting T cells, but is induced after the initial steps of T cell activation. To address the regulation of CTLA4 expression, we have analyzed CTLA4 at the level of cell surface expression, mRNA, rate of transcription, and rate of decay of message. Nuclear runoff results show an increase in the rate of transcription following T cell activation. Our analyses of non-T cells, including B cells, mastocytoma, and fibroblasts, by Northern blot analysis detect only T cell expression of CTLA4. Reporter gene analysis indicates that 335 bp of upstream CTLA4 sequence are sufficient to control inducibility. We have identified important regulatory regions that control inducible and cell-specific CTLA4 expression. These results also suggest that both positive and negative response elements modulate the transcriptional regulation of CTLA4 gene expression. Understanding the regulation of CTLA4 should provide insight into the regulation of T cell activation at the molecular level.

摘要

T细胞活化至少需要两个不同的信号,包括通过抗原特异性TCR的信号传导和共刺激途径。最具特征的共刺激途径涉及CD28分子,其在T细胞上组成性表达,并与APC上的B7反受体家族结合。抑制该共刺激途径可防止T细胞活化,并可导致长期的T细胞无反应性或无能。相比之下,与CD28同源的CTLA4已被证明是T细胞活化的负调节因子。CTLA4分子在静息T细胞上不表达,但在T细胞活化的初始步骤后被诱导。为了研究CTLA4表达的调控,我们在细胞表面表达、mRNA、转录速率和信息衰减速率水平上分析了CTLA4。核转录分析结果显示T细胞活化后转录速率增加。我们通过Northern印迹分析对包括B细胞、肥大细胞瘤和成纤维细胞在内的非T细胞进行分析,仅检测到CTLA4的T细胞表达。报告基因分析表明,CTLA4上游序列的335 bp足以控制诱导性。我们已经鉴定出控制诱导性和细胞特异性CTLA4表达的重要调控区域。这些结果还表明,正负反应元件均调节CTLA4基因表达的转录调控。了解CTLA4的调控应该能在分子水平上深入了解T细胞活化的调控。

相似文献

1
Regulation of CTLA-4 expression during T cell activation.T细胞激活过程中CTLA-4表达的调控。
J Immunol. 1996 Jun 1;156(11):4154-9.
2
Synergistic induction of CTLA-4 expression by costimulation with TCR plus CD28 signals mediated by increased transcription and messenger ribonucleic acid stability.通过TCR加CD28信号共刺激,由转录增加和信使核糖核酸稳定性介导,协同诱导CTLA-4表达。
J Immunol. 1997 May 1;158(9):4074-81.
3
Expression and functional significance of CTLA-4, a negative regulator of T cell activation.T细胞活化负调节因子CTLA-4的表达及功能意义
Arch Immunol Ther Exp (Warsz). 2001;49(1):39-46.
4
CTLA-4 and CD28 mRNA are coexpressed in most T cells after activation. Expression of CTLA-4 and CD28 mRNA does not correlate with the pattern of lymphokine production.CTLA-4和CD28信使核糖核酸在大多数T细胞激活后共同表达。CTLA-4和CD28信使核糖核酸的表达与淋巴因子产生模式无关。
J Immunol. 1992 Dec 15;149(12):3795-801.
5
CD28 engagement by B7/BB-1 induces transient down-regulation of CD28 synthesis and prolonged unresponsiveness to CD28 signaling.B7/BB-1与CD28结合会诱导CD28合成的短暂下调以及对CD28信号的长期无反应性。
J Immunol. 1993 Apr 15;150(8 Pt 1):3161-9.
6
Characterization of CTLA-4 structure and expression on human T cells.CTLA-4在人T细胞上的结构及表达特征
J Immunol. 1993 Oct 1;151(7):3489-99.
7
B7.2 expressed by T cells does not induce CD28-mediated costimulatory activity but retains CTLA4 binding: implications for induction of antitumor immunity to T cell tumors.T细胞表达的B7.2不诱导CD28介导的共刺激活性,但保留CTLA4结合能力:对T细胞肿瘤抗肿瘤免疫诱导的意义。
J Immunol. 1997 Mar 1;158(5):2025-34.
8
CD28/CTLA4-B7 interaction is dispensable for T cell stimulation by mouse mammary tumor virus superantigen but not for B cell differentiation and virus dissemination.CD28/CTLA4与B7的相互作用对于小鼠乳腺肿瘤病毒超抗原刺激T细胞而言并非必需,但对于B细胞分化和病毒传播却是必需的。
Eur J Immunol. 1996 Jul;26(7):1595-602. doi: 10.1002/eji.1830260728.
9
Molecular cloning and expression of early T cell costimulatory molecule-1 and its characterization as B7-2 molecule.早期T细胞共刺激分子-1的分子克隆、表达及其作为B7-2分子的特性
J Immunol. 1994 May 15;152(10):4929-36.
10
Regulation of surface and intracellular expression of CTLA4 on mouse T cells.小鼠T细胞上CTLA4的表面和细胞内表达调控。
J Immunol. 1996 Dec 1;157(11):4762-70.

引用本文的文献

1
Investigating the functional and structural effect of non-synonymous single nucleotide polymorphisms in the cytotoxic T-lymphocyte antigen-4 gene: An in-silico study.研究细胞毒性T淋巴细胞抗原4基因非同义单核苷酸多态性的功能和结构效应:一项计算机模拟研究。
PLoS One. 2025 Jan 24;20(1):e0316465. doi: 10.1371/journal.pone.0316465. eCollection 2025.
2
CD28 shapes T cell receptor signaling by regulating Lck dynamics and ZAP70 activation.CD28通过调节Lck动力学和ZAP70激活来塑造T细胞受体信号传导。
Front Immunol. 2024 Dec 24;15:1503018. doi: 10.3389/fimmu.2024.1503018. eCollection 2024.
3
Nanobodies as innovative immune checkpoint modulators: advancing cancer immunotherapy.
纳米抗体作为创新的免疫检查点调节剂:推动癌症免疫治疗
Med Oncol. 2024 Dec 24;42(1):36. doi: 10.1007/s12032-024-02588-y.
4
Immune checkpoints and ncRNAs: pioneering immunotherapy approaches for hematological malignancies.免疫检查点与非编码RNA:血液系统恶性肿瘤的开创性免疫治疗方法
Cancer Cell Int. 2024 Dec 19;24(1):410. doi: 10.1186/s12935-024-03596-8.
5
Vδ2 T-cell engagers bivalent for Vδ2-TCR binding provide anti-tumor immunity and support robust Vγ9Vδ2 T-cell expansion.对Vδ2-TCR结合具有双价性的Vδ2 T细胞衔接器可提供抗肿瘤免疫力,并支持强大的Vγ9Vδ2 T细胞扩增。
Front Oncol. 2024 Oct 18;14:1474007. doi: 10.3389/fonc.2024.1474007. eCollection 2024.
6
Immune checkpoint pathways in glioblastoma: a diverse and evolving landscape.胶质母细胞瘤中的免疫检查点途径:一个多样化且不断发展的领域。
Front Immunol. 2024 Sep 13;15:1424396. doi: 10.3389/fimmu.2024.1424396. eCollection 2024.
7
The miRNA and PD-1/PD-L1 signaling axis: an arsenal of immunotherapeutic targets against lung cancer.微小RNA与程序性死亡蛋白1/程序性死亡配体1信号轴:肺癌免疫治疗靶点的宝库
Cell Death Discov. 2024 Sep 29;10(1):414. doi: 10.1038/s41420-024-02182-1.
8
Regulatory T cell homing and activation is a signature of neonatal sepsis.调节性 T 细胞归巢和激活是新生儿败血症的特征。
Front Immunol. 2024 Jul 12;15:1420554. doi: 10.3389/fimmu.2024.1420554. eCollection 2024.
9
Novel treatments in optic pathway gliomas.视路胶质瘤的新型治疗方法。
Front Ophthalmol (Lausanne). 2022 Sep 29;2:992673. doi: 10.3389/fopht.2022.992673. eCollection 2022.
10
Mechanisms of tumor immunosuppressive microenvironment formation in esophageal cancer.食管癌肿瘤免疫抑制微环境形成的机制。
World J Gastroenterol. 2024 Apr 28;30(16):2195-2208. doi: 10.3748/wjg.v30.i16.2195.